Doxycycline: Uses, Dosage & Side Effects

Tetracycline antibiotic for bacterial infections, Lyme disease, chlamydia and more

Rx – Prescription Only ATC: J01AA02 Tetracycline Antibiotic
Active Ingredient
Doxycycline (as hyclate or monohydrate)
Available Forms
Capsule, tablet, oral solution, IV infusion
Common Strengths
40 mg, 50 mg, 100 mg, 200 mg
Known Brands
Doxyferm, Oracea, Vibramycin, Doryx
Medically reviewed | Last reviewed: | Evidence level: 1A
Doxycycline is a widely used tetracycline antibiotic that prevents bacterial growth by inhibiting protein synthesis. It is prescribed for a broad range of infections including pneumonia, Lyme disease (Borrelia infection), chlamydia, sinusitis, and acne. Doxycycline requires a prescription and must not be used during pregnancy, breastfeeding, or in children under 8 years unless absolutely necessary.
📅 Published: | Updated:
Reading time: 15 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in clinical pharmacology

📊 Quick Facts About Doxycycline

Active Ingredient
Doxycycline
Tetracycline class
Drug Class
Tetracycline
Bacteriostatic antibiotic
ATC Code
J01AA02
Tetracyclines
Common Uses
Lyme, STIs
Pneumonia, acne, malaria
Available Forms
Oral & IV
Capsule, tablet, solution
Prescription Status
Rx Only
Prescription required

💡 Key Takeaways About Doxycycline

  • Broad-spectrum antibiotic: Doxycycline treats a wide range of bacterial infections including Lyme disease, chlamydia, pneumonia, sinusitis and acne
  • Sun sensitivity is a major concern: Avoid sun exposure and tanning beds during treatment and for at least 5 days after stopping – severe sunburn-like reactions can occur
  • Not for children under 8 or pregnant women: Can cause permanent tooth discolouration and bone growth problems in developing children and foetuses
  • Take correctly to avoid oesophageal damage: Swallow with a full glass of water and remain upright for at least 30 minutes afterwards
  • Many drug interactions: Antacids, iron supplements and calcium products reduce absorption – space them at least 2–3 hours apart

What Is Doxycycline and What Is It Used For?

Doxycycline is a tetracycline antibiotic that works by preventing bacteria from producing the proteins they need to grow and multiply. It is used to treat infections of the lungs, urinary tract, skin and soft tissues, as well as Lyme disease, sexually transmitted infections and malaria prophylaxis.

Doxycycline belongs to the tetracycline family of antibiotics. Unlike bactericidal antibiotics that kill bacteria directly, doxycycline is bacteriostatic, meaning it stops bacteria from growing and reproducing. It does this by binding to the 30S ribosomal subunit inside bacterial cells, which blocks the attachment of transfer RNA (tRNA) to the messenger RNA-ribosome complex. Without this critical step, bacteria cannot synthesise the proteins they need to survive and replicate.

One of the major clinical advantages of doxycycline is its remarkably broad spectrum of activity. It is effective against a wide range of Gram-positive bacteria (such as Streptococcus pneumoniae and Staphylococcus aureus), Gram-negative bacteria (such as Haemophilus influenzae and Neisseria gonorrhoeae), atypical organisms (including Chlamydia trachomatis, Mycoplasma pneumoniae and Borrelia burgdorferi), and even certain protozoa such as Plasmodium species that cause malaria.

Doxycycline is well absorbed from the gastrointestinal tract, even when taken with food, which is a significant advantage over older tetracyclines. It has a long half-life of approximately 18–22 hours, allowing for convenient once- or twice-daily dosing. The drug is widely distributed throughout the body, achieving therapeutic concentrations in the lungs, sinuses, skin, urogenital tract and other tissues.

Common indications for doxycycline

Doxycycline is one of the most versatile antibiotics available and is prescribed for a diverse range of conditions. The most common therapeutic uses include:

  • Lyme disease (Borrelia infection): First-line treatment for early Lyme disease following a tick bite, typically prescribed for 10–21 days depending on the stage of infection
  • Chlamydia and other sexually transmitted infections: Effective against Chlamydia trachomatis, Ureaplasma urealyticum, and as an alternative treatment for syphilis and gonorrhoea
  • Community-acquired pneumonia: Used when atypical pathogens are suspected or in patients allergic to penicillin
  • Acute bacterial sinusitis: Second-line treatment for patients who are allergic to penicillins or when first-line therapy has failed
  • Acute exacerbation of chronic bronchitis: When bacterial infection is contributing to worsening of underlying chronic obstructive pulmonary disease
  • Acne vulgaris: Moderate-to-severe inflammatory acne, usually prescribed for 6–12 weeks
  • Rosacea: At sub-antimicrobial doses (40 mg modified-release), doxycycline reduces the inflammatory lesions of rosacea
  • Malaria prophylaxis: Recommended for travellers visiting areas with chloroquine-resistant Plasmodium falciparum malaria
  • Urinary tract infections: When susceptibility testing confirms doxycycline sensitivity
  • Periodontal disease: As an adjunct to scaling and root planing at sub-antimicrobial doses
Important: Doxycycline only works against bacteria

Like all antibiotics, doxycycline is not effective against viral infections such as the common cold or influenza. Using antibiotics unnecessarily contributes to antibiotic resistance, which is a growing global public health threat identified by the WHO as one of the top 10 threats to global health.

What Should You Know Before Taking Doxycycline?

Before taking doxycycline, tell your doctor if you are pregnant, breastfeeding, have liver disease, myasthenia gravis, or are allergic to tetracycline antibiotics. Doxycycline is contraindicated in pregnancy, during breastfeeding, and generally in children under 8 years of age.

Doxycycline is a highly effective antibiotic, but it is not suitable for everyone. Before starting treatment, your prescribing doctor needs to be aware of your complete medical history, current medications and any allergies. Certain medical conditions and life stages make doxycycline unsafe or require careful dose adjustment and monitoring throughout the course of treatment.

Contraindications

You must not take doxycycline if any of the following apply to you:

  • Allergy to doxycycline or any tetracycline antibiotic: If you have previously experienced an allergic reaction to doxycycline, tetracycline, minocycline, or any other tetracycline-class antibiotic, you must not take this medication. Symptoms of an allergic reaction include rash, itching, swelling of the face or throat, and difficulty breathing.
  • Pregnancy: Doxycycline crosses the placenta and can cause permanent tooth discolouration (yellow-grey-brown staining), enamel hypoplasia and adverse effects on skeletal development in the foetus. These effects are most significant during the second and third trimesters, but doxycycline should be avoided throughout pregnancy.
  • Breastfeeding: Doxycycline passes into breast milk and may affect bone and tooth development in the nursing infant. Alternative antibiotics that are safe during breastfeeding should be used instead.
  • Children under 8 years of age: Tetracycline antibiotics bind permanently to developing teeth and bones, causing irreversible tooth discolouration and potentially affecting skeletal growth. In rare, serious or life-threatening situations where no alternative exists, the prescribing physician may determine that the benefits outweigh these risks.

Warnings and Precautions

Talk to your doctor before taking doxycycline if you have any of the following conditions, as your treatment may need to be modified or closely monitored:

  • Myasthenia gravis: Doxycycline may worsen muscle weakness in patients with this neuromuscular condition. If you have myasthenia gravis, your doctor will carefully weigh the risks and benefits before prescribing.
  • Liver disease or impaired liver function: Doxycycline is partially metabolised by the liver. In patients with significant hepatic impairment, the drug may accumulate to toxic levels. Your doctor may need to adjust the dose or choose an alternative antibiotic.
  • Oesophageal conditions: Doxycycline can cause severe oesophageal ulceration and irritation if the capsule or tablet lodges in the oesophagus. Always take doxycycline with a full glass of water (at least 200 ml) and remain in an upright position for at least 30 minutes after swallowing the dose.
Photosensitivity warning

Doxycycline significantly increases your skin's sensitivity to ultraviolet light. To prevent severe sunburn-like reactions, you should avoid direct sunlight, sunlamps and tanning beds during the entire course of treatment and for at least 5 days after completing the course. If sun exposure is unavoidable, use broad-spectrum SPF 50+ sunscreen, wear protective clothing, a wide-brimmed hat and sunglasses.

Pregnancy and Breastfeeding

Doxycycline is strictly contraindicated during pregnancy and breastfeeding. The evidence for these restrictions is well established and supported by all major regulatory agencies worldwide, including the EMA, FDA, WHO and MHRA.

During pregnancy, doxycycline crosses the placental barrier and accumulates in developing foetal teeth and bones. This can cause permanent yellow-grey-brown discolouration of teeth and enamel hypoplasia (defective tooth enamel) in the child. Additionally, tetracyclines can be deposited in growing bone, which may temporarily inhibit skeletal growth. These effects are particularly concerning during the second and third trimesters when tooth and bone mineralisation is actively occurring.

During breastfeeding, doxycycline is excreted in breast milk, though concentrations are relatively low. The American Academy of Pediatrics has noted that short courses may be acceptable in certain circumstances, but most guidelines recommend avoiding doxycycline during lactation due to the theoretical risk to the infant's developing teeth and bones. Your doctor will prescribe a safer alternative such as amoxicillin, azithromycin or another antibiotic compatible with breastfeeding.

If you discover you are pregnant while taking doxycycline, stop the medication immediately and contact your doctor. A single dose or very short exposure in early pregnancy is unlikely to cause harm, but continued use should be avoided.

Driving and operating machinery

Doxycycline is not known to impair the ability to drive or operate machinery. However, as with any medication, you should be aware of how it affects you personally before engaging in activities requiring alertness. If you experience dizziness, blurred vision or other side effects that could impair concentration, refrain from driving until these effects resolve.

How Does Doxycycline Interact with Other Drugs?

Doxycycline has clinically significant interactions with antacids, iron supplements, calcium, warfarin, isotretinoin, rifampicin and anti-epileptic drugs. Antacids and minerals reduce absorption, while certain enzyme-inducing drugs can reduce doxycycline's effectiveness.

Drug interactions are an important consideration with doxycycline because several commonly used medications can either reduce its effectiveness or increase the risk of adverse effects. Before starting doxycycline, you should provide your doctor and pharmacist with a complete list of all medications, supplements and herbal products you are currently taking. This includes prescription drugs, over-the-counter medicines, vitamins and dietary supplements.

Major Interactions – Avoid Concurrent Use

The following medications should be avoided while taking doxycycline, or require careful management if co-administration is necessary:

Drugs that have major interactions with doxycycline
Interacting Drug Effect Recommendation
Antacids (aluminium, magnesium, calcium) Form insoluble chelates with doxycycline, dramatically reducing absorption by up to 90% Avoid antacids or take at least 2–3 hours before or after doxycycline
Iron supplements Iron chelates with tetracyclines, reducing absorption of both the antibiotic and the iron Space at least 2–3 hours apart; take doxycycline first
Isotretinoin (for severe acne) Combined use significantly increases the risk of benign intracranial hypertension (pseudotumour cerebri) Do not use together; choose one or the other for acne treatment
Quinapril (ACE inhibitor) Magnesium carbonate in quinapril formulation chelates doxycycline, reducing absorption Space at least 2–3 hours apart
Atovaquone (for malaria/pneumocystis) Doxycycline may reduce plasma concentrations of atovaquone Avoid concurrent use; consult your doctor for alternatives
Didanosine (antiviral) Buffered formulations of didanosine contain antacids that reduce doxycycline absorption Space at least 2 hours apart or use enteric-coated didanosine

Moderate Interactions – Use with Caution

The following drugs may interact with doxycycline and require dose adjustment, monitoring or careful timing of administration:

Drugs that have moderate interactions with doxycycline
Interacting Drug Effect Recommendation
Warfarin and other anticoagulants Doxycycline may enhance the anticoagulant effect by reducing vitamin K-producing gut bacteria and potentially displacing warfarin from protein binding sites Monitor INR closely; warfarin dose reduction may be needed
Rifampicin (for tuberculosis) Rifampicin induces hepatic enzymes that increase doxycycline metabolism, potentially reducing therapeutic levels by 50% or more Avoid combination if possible; if necessary, increase doxycycline dose and monitor efficacy
Phenobarbital, phenytoin, carbamazepine These anti-epileptic drugs induce hepatic enzymes, increasing doxycycline metabolism and reducing its half-life May require higher doxycycline doses; monitor treatment response
Calcium supplements Calcium chelates with doxycycline, reducing absorption Take calcium at least 3 hours before or after doxycycline
Oral contraceptives Antibiotics may theoretically reduce the efficacy of combined oral contraceptives by disrupting gut flora involved in enterohepatic recirculation of oestrogens Use additional contraceptive methods during treatment and for 7 days after
Methotrexate Doxycycline may increase methotrexate levels by reducing its renal tubular secretion Monitor for methotrexate toxicity; blood tests may be needed

Doxycycline and alcohol

The effectiveness of doxycycline may be reduced when taken with alcohol. While the interaction is not as severe as with some other antibiotics, alcohol can increase the hepatic metabolism of doxycycline, particularly in heavy drinkers, potentially leading to subtherapeutic blood levels. Alcohol can also exacerbate gastrointestinal side effects such as nausea, vomiting and stomach upset. For the best treatment outcome, it is advisable to minimise or avoid alcohol consumption during the course of antibiotic therapy.

What Is the Correct Dosage of Doxycycline?

The standard adult dose of doxycycline is 200 mg on the first day (as a loading dose), followed by 100 mg once daily. Dosage varies by indication: Lyme disease typically requires 100 mg twice daily for 14–21 days, while chlamydia is treated with 100 mg twice daily for 7 days.

The dose of doxycycline is determined by your doctor based on the type and severity of your infection, your age, body weight and kidney/liver function. It is crucial to follow your prescribed dosage exactly and to complete the full course of treatment, even if you start feeling better before the course is finished. Stopping antibiotics early increases the risk of antibiotic resistance and may allow the infection to return.

Adults and Adolescents (Over 12 Years)

The standard dosing regimen for most infections in adults is a loading dose of 200 mg on the first day (given as a single dose or as 100 mg every 12 hours), followed by a maintenance dose of 100 mg once daily. For more severe infections, the higher dose of 200 mg daily may be continued throughout the treatment course.

Recommended doxycycline dosages for common conditions in adults
Condition Dose Duration Notes
Lyme disease (early) 100 mg twice daily 14–21 days First-line treatment per IDSA/NICE guidelines
Chlamydia 100 mg twice daily 7 days First-line treatment; sexual partners should also be treated
Community-acquired pneumonia 100 mg twice daily 7–14 days Covers atypical pathogens; may be combined with beta-lactam
Acute sinusitis 100 mg twice daily or 200 mg once daily 7–10 days Alternative for penicillin-allergic patients
Acne vulgaris 50–100 mg once daily 6–12 weeks Often combined with topical retinoids
Rosacea 40 mg modified-release once daily 12–16 weeks Sub-antimicrobial dose; anti-inflammatory effect
Malaria prophylaxis 100 mg once daily Start 1–2 days before travel; continue 4 weeks after For chloroquine-resistant areas

Children (8 to 12 Years)

Doxycycline should only be used in children aged 8 to 12 years when other antibiotics are not available, not appropriate, or unlikely to be effective. Under these circumstances, the dosage is based on body weight:

Children weighing 45 kg or less

  • Day 1 (loading dose): 4.4 mg per kg body weight, given as a single dose or divided into two doses
  • Day 2 onwards: 2.2 mg per kg body weight, given as a single dose or divided into two doses
  • Severe infections: 4.4 mg per kg body weight may be continued throughout the treatment course

Children weighing over 45 kg

Same dose as adults: 200 mg on day 1 followed by 100 mg daily (or 100 mg twice daily for severe infections).

Children under 8 years

Doxycycline should generally not be given to children under 8 years of age. Tetracycline antibiotics can cause permanent tooth discolouration and affect bone development in young children. In rare circumstances involving severe or life-threatening conditions, the prescribing physician may determine that the benefits outweigh these risks.

Elderly Patients

No specific dose adjustment is required for elderly patients with normal liver and kidney function. However, elderly individuals may be more susceptible to oesophageal irritation, so extra care should be taken to swallow the medication with plenty of water and to remain upright afterwards. Elderly patients on anticoagulant therapy (such as warfarin) should have their INR monitored more frequently when starting or stopping doxycycline.

Missed Dose

If you miss a dose of doxycycline, take it as soon as you remember. If it is nearly time for the next scheduled dose, skip the missed dose and take the next dose at the regular time. Do not take a double dose to compensate for the one you missed. Consistently missing doses may reduce the effectiveness of the antibiotic and contribute to the development of resistant bacteria.

Overdose

Symptoms of doxycycline overdose may include severe nausea, vomiting and diarrhoea. If you suspect an overdose, contact your local poison control centre or seek emergency medical attention immediately. Treatment is primarily supportive, as doxycycline is not efficiently removed by haemodialysis or peritoneal dialysis.

How to take doxycycline correctly

To minimise the risk of oesophageal irritation and ensure optimal absorption:

  • Swallow the capsule or tablet whole with a full glass of water (at least 200 ml)
  • Remain upright (sitting or standing) for at least 30 minutes after taking the dose
  • Do not take doxycycline immediately before bedtime or lying down
  • Doxycycline can be taken with food to reduce stomach upset (unlike older tetracyclines)
  • Avoid dairy products, antacids and iron supplements within 2–3 hours of your dose

What Are the Side Effects of Doxycycline?

The most common side effects of doxycycline are nausea, vomiting and diarrhoea (affecting up to 1 in 10 patients). Less common effects include photosensitivity skin reactions and rash. Rare but serious side effects include severe allergic reactions, oesophageal ulceration and increased intracranial pressure.

Like all medicines, doxycycline can cause side effects, although not everyone experiences them. Most side effects are mild and resolve on their own once the course of treatment is completed. However, some side effects require immediate medical attention. If you experience any symptoms that concern you, contact your doctor or pharmacist promptly.

Seek immediate medical attention if you experience:
  • Sudden skin rash, fever, difficulty breathing or facial swelling (signs of anaphylactic reaction)
  • Severe skin reactions with blistering or sores in the mouth, eyes or genital area (erythema multiforme, Stevens-Johnson syndrome)
  • Signs of Jarisch-Herxheimer reaction: fever, chills, headache, muscle pain and skin rash occurring shortly after starting doxycycline for spirochaetal infections such as Lyme disease – these symptoms are usually self-limiting

Common Side Effects

May affect up to 1 in 10 patients

  • Nausea
  • Vomiting
  • Diarrhoea
  • Abdominal discomfort
  • Loss of appetite

Uncommon Side Effects

May affect up to 1 in 100 patients

  • Skin rash and urticaria (hives)
  • Photosensitivity reactions (exaggerated sunburn)
  • Vaginal candidiasis (thrush)
  • Oral candidiasis (oral thrush)

Rare Side Effects

May affect up to 1 in 1,000 patients

  • Hypersensitivity reactions (allergic reactions)
  • Thrombocytopenia (low platelet count)
  • Onycholysis (nail detachment)
  • Raised intracranial pressure (pseudotumour cerebri) – symptoms include headache and visual disturbances
  • Colitis (inflammation of the large intestine)
  • DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) – fever, rash, abnormal blood counts and organ involvement

Frequency Not Known

Cannot be estimated from available data

  • Tooth discolouration and enamel hypoplasia (in developing teeth)
  • Liver damage (hepatotoxicity)
  • Oesophageal ulceration and oesophagitis
  • Jarisch-Herxheimer reaction (when treating Lyme disease or syphilis)
  • Fungal overgrowth of oral or vaginal mucosa

If you notice prolonged or troublesome diarrhoea during or after your course of doxycycline, contact your doctor. This may indicate antibiotic-associated colitis (including Clostridioides difficile infection), which requires prompt medical evaluation and treatment.

Fungal overgrowth (candidiasis) of the mouth or vagina may occasionally occur because doxycycline disrupts the normal bacterial flora, allowing opportunistic fungi to proliferate. If thrush develops and persists for several days or is severe, contact your doctor for antifungal treatment.

How Should You Store Doxycycline?

Store doxycycline capsules and tablets at room temperature (below 25°C), away from direct sunlight and moisture. Keep out of reach of children. Do not use after the expiry date. The concentrate for intravenous infusion must be stored in a refrigerator (2–8°C) and protected from light.

Proper storage is essential to ensure that doxycycline remains effective and safe throughout its shelf life. Degraded tetracycline antibiotics can become toxic, potentially causing a condition known as Fanconi syndrome (renal tubular damage). While this risk is primarily associated with expired tetracycline rather than doxycycline specifically, it underscores the importance of not using any antibiotic past its expiry date.

  • Capsules and tablets: Store at room temperature (15–25°C) in the original packaging to protect from moisture and light. Do not store in the bathroom, as humidity can degrade the medication.
  • Oral suspension: Once reconstituted, store in a refrigerator and use within 14 days unless otherwise directed by the manufacturer.
  • Concentrate for IV infusion: Store in a refrigerator (2–8°C) in the original carton to protect from light. After dilution, the infusion solution should be used within 6 hours and protected from direct sunlight.
  • General rules: Keep all medications out of sight and reach of children. Do not use doxycycline after the expiry date printed on the packaging. Do not dispose of medications via household waste or down the drain – return unused medicines to your pharmacy for safe disposal.

What Does Doxycycline Contain?

The active ingredient is doxycycline, available as doxycycline hyclate or doxycycline monohydrate. Inactive ingredients vary by formulation and manufacturer but typically include lactose, magnesium stearate, microcrystalline cellulose and various capsule shell components.

Doxycycline is available in multiple formulations from different manufacturers. The active substance is doxycycline itself, though it is formulated as different salt forms depending on the product:

  • Doxycycline hyclate (hydrochloride hemiethanolate hemihydrate): The most common salt form used in oral capsules, tablets and the intravenous concentrate. Doxycycline hyclate dissolves readily in water and is rapidly absorbed.
  • Doxycycline monohydrate: Used in some oral formulations, particularly those designed for improved gastrointestinal tolerability. It may cause slightly less oesophageal irritation compared to the hyclate form.

For the intravenous formulation (concentrate for infusion at 20 mg/ml), the additional inactive ingredients include ethanolamine, magnesium chloride hexahydrate, povidone, acetylcysteine and water for injections. The concentrate appears as a clear, yellowish liquid and is supplied in glass ampoules containing 5 ml (equivalent to 100 mg doxycycline).

Common inactive ingredients in oral capsule and tablet formulations may include:

  • Microcrystalline cellulose
  • Lactose monohydrate
  • Magnesium stearate
  • Sodium lauryl sulfate
  • Povidone
  • Gelatin and titanium dioxide (capsule shell)

If you have known allergies to any excipients (such as lactose intolerance), check the specific product information leaflet supplied with your medication or consult your pharmacist before taking doxycycline.

Frequently Asked Questions About Doxycycline

Doxycycline is a broad-spectrum tetracycline antibiotic used to treat a wide range of bacterial infections. Common uses include Lyme disease (Borrelia infection after tick bites), chlamydia and other sexually transmitted infections, community-acquired pneumonia, sinusitis in penicillin-allergic patients, acne vulgaris, rosacea, urinary tract infections and malaria prophylaxis for travellers to endemic areas. It is not effective against viral infections such as the common cold or flu.

It is advisable to limit or avoid alcohol while taking doxycycline. Alcohol can reduce the effectiveness of doxycycline by increasing its metabolism in the liver, particularly in regular drinkers, potentially leading to subtherapeutic drug levels. Alcohol also worsens common gastrointestinal side effects such as nausea and stomach upset. While a single drink is unlikely to cause serious problems, minimising alcohol intake during the treatment course will give the antibiotic the best chance of working effectively.

Doxycycline causes photosensitivity, meaning your skin becomes significantly more sensitive to ultraviolet (UV) radiation from sunlight and artificial sources like tanning beds. Even brief sun exposure can cause severe sunburn-like reactions, including redness, blistering and peeling. This occurs because doxycycline molecules in the skin absorb UV energy and generate reactive oxygen species that damage skin cells. You should avoid direct sunlight during treatment and for at least 5 days after completing the course. If outdoor activity is unavoidable, use broad-spectrum SPF 50+ sunscreen, wear protective clothing, a wide-brimmed hat and seek shade.

Doxycycline begins working within hours of the first dose as it reaches therapeutic concentrations in the blood and tissues. However, noticeable improvement in symptoms typically occurs within 24 to 48 hours for acute infections. For conditions like Lyme disease or respiratory infections, patients often feel significantly better within 2 to 3 days. For chronic conditions such as acne or rosacea, it may take 4 to 12 weeks to see substantial improvement. Regardless of how quickly you feel better, it is essential to complete the full prescribed course to prevent the infection from returning and to reduce the risk of antibiotic resistance.

Doxycycline should generally not be given to children under 8 years of age because tetracycline antibiotics can permanently stain developing teeth (causing yellow-grey-brown discolouration) and affect skeletal development. In rare cases involving serious or life-threatening infections where no suitable alternative exists, a doctor may decide that the benefits outweigh these risks. Children aged 8 to 12 years may receive doxycycline when other antibiotics are unavailable or ineffective, with dosing calculated based on body weight (4.4 mg/kg on day 1, then 2.2 mg/kg daily). Children weighing over 45 kg receive the same dose as adults.

If you miss a dose of doxycycline, take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. Never take a double dose to compensate for the one you missed. Missing doses consistently can reduce the effectiveness of the treatment and increase the risk of developing antibiotic-resistant bacteria. If you have difficulty remembering your doses, consider setting a daily alarm on your phone or using a pill organiser to help you stay on track.

No, doxycycline is strictly contraindicated during pregnancy. It crosses the placenta and can cause permanent tooth discolouration (yellow-grey-brown staining), defective tooth enamel (enamel hypoplasia) and adverse effects on skeletal development in the unborn child. These risks are greatest during the second and third trimesters. If you discover you are pregnant while taking doxycycline, stop the medication and contact your doctor immediately. Your doctor will prescribe a safer alternative antibiotic. Doxycycline is also not recommended during breastfeeding as it passes into breast milk.

References

This article is based on the following evidence-based sources, international guidelines and peer-reviewed research:

  1. World Health Organization (WHO). Model List of Essential Medicines – 23rd List (2023). Doxycycline listed as an essential antimicrobial agent. Geneva: WHO; 2023.
  2. European Medicines Agency (EMA). Doxycycline – Summary of Product Characteristics. EMA European Public Assessment Reports. Available at: www.ema.europa.eu
  3. U.S. Food and Drug Administration (FDA). Doxycycline Hyclate – FDA Prescribing Information. Updated 2024. Available at: www.accessdata.fda.gov
  4. British National Formulary (BNF). Doxycycline – Drug monograph. National Institute for Health and Care Excellence. Available at: bnf.nice.org.uk
  5. Lansbury L, et al. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013;347:f6153.
  6. Wormser GP, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134. doi:10.1086/508667
  7. NICE Clinical Guideline [NG95]. Lyme disease. National Institute for Health and Care Excellence; 2018 (updated 2022). Available at: www.nice.org.uk/guidance/ng95
  8. Workowski KA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1
  9. Smilack JD. The tetracyclines. Mayo Clin Proc. 1999;74(7):727-729. doi:10.4065/74.7.727
  10. Holmes NE, Charles PGP. Safety and Efficacy Review of Doxycycline. Clin Med Ther. 2009;1:471-482.

About the Medical Editorial Team

This article has been written and reviewed by the iMedic Medical Editorial Team, comprising specialist physicians in clinical pharmacology, infectious diseases and internal medicine. All medical content follows the GRADE evidence framework and is based on the highest quality available evidence (Level 1A where possible).

Medical Writing

iMedic Medical Editorial Team – specialists in clinical pharmacology and antimicrobial therapy with extensive clinical and academic experience.

Medical Review

iMedic Medical Review Board – independent panel of medical experts who review all content according to international guidelines (WHO, EMA, FDA, BNF, NICE).

Editorial Standards

All content on iMedic is evidence-based and follows international medical guidelines. We have no commercial funding, no pharmaceutical sponsorship and no advertising. Our editorial standards are available at /en/about/editorial-standards.